Watkinson
Adam Watkinson, West Melbourne AU
Patent application number | Description | Published |
---|---|---|
20130317462 | TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS - A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300. | 11-28-2013 |
Adam Watkinson, Victoria AU
Patent application number | Description | Published |
---|---|---|
20100279988 | TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS - A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300. | 11-04-2010 |
20100297032 | TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C | 11-25-2010 |
20100322884 | METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY - The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition. | 12-23-2010 |
Adam Watkinson, Williamstown AU
Patent application number | Description | Published |
---|---|---|
20150087623 | METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY - The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition. | 03-26-2015 |
Adam Watkinson, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20130317122 | TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C | 11-28-2013 |
20160022820 | TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C | 01-28-2016 |
Adam Charles Watkinson, Newport AU
Patent application number | Description | Published |
---|---|---|
20150088080 | SPREADING IMPLEMENT - This invention relates to an implement | 03-26-2015 |
Adam Charles Watkinson, Victoria AU
Patent application number | Description | Published |
---|---|---|
20120220959 | SPREADING IMPLEMENT - This invention relates to an implement | 08-30-2012 |
20130211350 | SPREADING IMPLEMENT - This invention relates to an implement | 08-15-2013 |
Alan Paul Watkinson, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20130230433 | FREEBOARD TAR DESTRUCTION UNIT - A tar destruction unit for a biomass gasifier is described, comprising a catalyst and/or heating means situated within the free-board section of the gasifier. Also described is a biomass gasifier having such a tar destruction unit. | 09-05-2013 |
Chevis James Watkinson, Appleton, WI US
Patent application number | Description | Published |
---|---|---|
20160135652 | SHEET PRODUCT DISPENSERS AND RELATED METHODS FOR PROTECTING A ROLL OF SHEET PRODUCT AND REDUCING WASTE - A sheet product dispenser for dispensing sheet product from a roll of sheet product is provided. The sheet product dispenser includes a housing defining an interior space configured to receive the roll of sheet product therein, and a roll support positioned within the interior space and configured to rotatably support the roll of sheet product. The housing includes a dispensing gap in communication with the interior space and configured to allow a tail portion of the roll of sheet product to extend therethrough and out of the interior space, and a drainage gap in communication with the interior space and configured to allow a liquid to drain therethrough and out of the interior space. The drainage gap is spaced apart from the dispensing gap and positioned below the dispensing gap. A related method of protecting a roll of sheet product within a sheet product dispenser also is provided. | 05-19-2016 |
Courtney Watkinson, Burbank, CA US
Patent application number | Description | Published |
---|---|---|
20120071062 | SYSTEMS AND METHODS TO COMMUNICATE AND CONTROL ACTIONS USING LIGHT EMITTING DIODES - In some embodiments, a signal of light may be emitted from an illumination source of a first transceiver. A second transceiver may detect a signal of light from the first transceiver that exceeds a threshold luminosity; and activate, in response to the detecting of the signal of light that exceeds the threshold luminosity, an illumination source of the second transceiver to illuminate. An intensity of the illumination source of the first transceiver may then be reduced in response to the activating of the illumination source of the second transceiver to illuminate. | 03-22-2012 |
20140111096 | SYSTEMS AND METHODS TO COMMUNICATE AND CONTROL ACTIONS USING LIGHT EMITTING DIODES - In some embodiments, a signal of light may be emitted from an illumination source of a first transceiver. A second transceiver may detect a signal of light from the first transceiver that exceeds a threshold luminosity; and activate, in response to the detecting of the signal of light that exceeds the threshold luminosity, an illumination source of the second transceiver to illuminate. An intensity of the illumination source of the first transceiver may then be reduced in response to the activating of the illumination source of the second transceiver to illuminate. | 04-24-2014 |
D. Tobin Watkinson, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20120269900 | COMPOSITIONS AND METHODS FOR A BUG REPELLENT - The present invention relates to compositions and methods for deterring and repelling all types of organisms capable of sensing electric or magnetic fields, including insects and arachnids. The compositions contain electrically or magnetically imprintable substances comprising an electric or magnetic charge or imprint, wherein the imprint contains the signature of at least one target organism; and an acceptable carrier. | 10-25-2012 |
D. Tobin Watkinson, Rancho Santa Fe, CA US
Patent application number | Description | Published |
---|---|---|
20090196852 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING IMMUNE DISORDERS - The present invention is a method of detection to identify antigen reactivity between infective agents, e.g., bacteria, viruses, parasites, bacteriophages, spirochetes, microbes and common foods, beverages, inhalants, chemical preparations, perfumes, fragrances, pollens, animal proteins and dander. As a result of the specific identification of the pathogenic agent/antigen reaction, a vaccine can be constructed to eradicate such allergic reaction. The test platform represents a series of impregnated test modules containing sample libraries of infective materials which have potential cross reactivity with a human subject's biological fluid sample and a reagent when needed. Sequential retesting or manual biopanning for the positive reactions; allergen/bacteria, bacteria/virus, result in the underlying antigen/pathogenic agent reaction. Once such causative infective agent relationship is identified there are several options for vaccine preparation or treatment to reduce or eradicate the identified causative pathogenic agent. | 08-06-2009 |
John Watkinson, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090012719 | SYSTEM AND METHOD FOR IDENTIFICATION OF SYNERGISTIC INTERACTIONS FROM CONTINUOUS DATA - Systems and methods for selecting factors from a continuous data set of measurements are provided. The measurements include values of factors and/or outcomes. Two or more factors that are jointly associated with one or more outcomes from the data set are identified. Each of the two or more factors are analyzed to determine at least one cooperative interaction among the factors with respect to an outcome. The two or more factors can be a module of factors serving as a single factor participating in a cooperative interaction with another factor or module of factors. | 01-08-2009 |
20110144917 | SYSTEM AND METHOD FOR IDENTIFICATION OF SYNERGISTIC INTERACTIONS FROM CONTINUOUS DATA - Systems and methods for selecting factors from a continuous data set of measurements are provided. The measurements include values of factors and/or outcomes. Two or more factors that are jointly associated with one or more outcomes from the data set are identified. Each of the two or more factors are analyzed to determine at least one cooperative interaction among the factors with respect to an outcome. The two or more factors can be a module of factors serving as a single factor participating in a cooperative interaction with another factor or module of factors. | 06-16-2011 |
John Watkinson, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20130040852 | BIOMARKERS BASED ON A MULTI-CANCER INVASION-ASSOCIATED MECHANISM - The present invention relates to biomarkers which constitute a metastasis associated fibroblast (“MAF”) signature and their use in diagnosing and staging a variety of cancers. It is based, at least in part, on the discovery that identifying the differential expression of certain genes indicates a diagnosis and/or stage of a variety of cancers with a high degree of specificity. In particular, the presence of the signature implies that the cancer has already become invasive. Accordingly, in various embodiments, the present invention provides for methods of diagnosis, diagnostic kits, as well as methods of treatment that include an assessment of biomarker status in a subject. Further, because the differential expression of certain genes can function as marker for the acquisition of metastatic potential, such expression profiles can be used to predict the appropriateness of certain therapeutic interventions, such as the appropriateness of neoadjuvant therapies. Such profiles can also be used to screen for therapeutics capable of inhibiting acquisition of metastatic potential. Accordingly, in various embodiments, the present invention provides for methods of screening therapeutics for their anti-metastatic properties as well as screening kits. | 02-14-2013 |
Kelly Watkinson, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20110082538 | MEDICAL DEVICE, KIT AND METHOD FOR CONSTRICTING TISSUE OR A BODILY ORIFICE, FOR EXAMPLE, A MITRAL VALVE - A device, kit and method may include or employ an implantable device (e.g., annuloplasty implant) and a tool operable to implant such. The implantable device is positionable in a cavity of a bodily organ (e.g., a heart) and operable to constrict a bodily orifice (e.g., a mitral valve). The tissue anchors may be guided into precise position by an intravascularly or percutaneously deployed anchor guide frame of the tool and embedded in an annulus of the orifice. Constriction of the orifice may be accomplished via a variety of structures, for example by cinching a flexible cable or via a anchored annuloplasty ring, the cable or ring attached to the tissue anchors. The annuloplasty ring may be delivered in an unanchored, generally elongated configuration, and implanted in an anchored generally arch, arcuate or annular configuration. Such may approximate the septal and lateral (clinically referred to as anterior and posterior) annulus of the mitral valve, to move the posterior leaflet anteriorly and the anterior leaflet posteriorly, thereby improving leaflet coaptation to eliminate mitral regurgitation. | 04-07-2011 |
20130345797 | MEDICAL DEVICE, KIT AND METHOD FOR CONSTRICTING TISSUE OR A BODILY ORIFICE, FOR EXAMPLE, A MITRAL VALVE - A device, kit and method may employ an implantable device (e.g., annuloplasty implant) and a tool to implant such. The implantable device is positionable in a cavity of a bodily organ (e.g., a heart) and operable to constrict a bodily orifice (e.g., a mitral valve). Tissue anchors are guided into precise position by an intravascularly deployed anchor guide frame and embedded in an annulus. Constriction of the orifice may be accomplished via a variety of structures, for example by cinching a flexible cable or anchored annuloplasty ring, the cable or ring attached to the tissue anchors. The annuloplasty ring may be delivered in a generally elongated configuration, and implanted in an anchored generally arch, arcuate or annular configuration. Such may move a posterior leaflet anteriorly and an anterior leaflet posteriorly, improving leaflet coaptation to eliminate mitral regurgitation. | 12-26-2013 |
20160081800 | MEDICAL DEVICE, KIT AND METHOD FOR CONSTRICTING TISSUE OR A BODILY ORIFICE, FOR EXAMPLE, A MITRAL VALVE - A device, kit and method may employ an implantable device (e.g., annuloplasty implant) and a tool to implant such. The implantable device is positionable in a cavity of a bodily organ (e.g., a heart) and operable to constrict a bodily orifice (e.g., a mitral valve). Tissue anchors are guided into precise position by an intravascularly deployed anchor guide frame and embedded in an annulus. Constriction of the orifice may be accomplished via a variety of structures, for example by cinching a flexible cable or anchored annuloplasty ring, the cable or ring attached to the tissue anchors. The annuloplasty ring may be delivered in a generally elongated configuration, and implanted in an anchored generally arch, arcuate or annular configuration. Such may move a posterior leaflet anteriorly and an anterior leaflet posteriorly, improving leaflet coaptation to eliminate mitral regurgitation. | 03-24-2016 |
Kelly Wilson Watkinson, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20150190616 | MEDICAL DEVICE INCLUDING MANIPULABLE PORTION WITH CONNECTED ELONGATE MEMBERS - A medical system may include a shaft member and a structure physically coupled to the shaft member. A portion of the shaft member may be sized to be delivered through a bodily opening leading to a bodily cavity. The structure may include at least two flexible couplings, each flexible coupling extending transversely from an intermediate portion of a respective one of at least two elongate members of the structure. The flexible coupling extending transversely from the intermediate portion of a first one of the at least two elongate members forms at least a part of a first closed loop arranged to receive a portion of the flexible coupling of a second one of the at least two elongate members therethrough to limit a spacing between the intermediate portions of the first and the second ones of the at least two elongate members. | 07-09-2015 |